Studies highlight role of molecular imaging in disease diagnosis

06/14/2010 | HealthImaging.com

An Australian study presented at the SNM annual meeting showed that the use of PET with carbon-11-labeled Pittsburgh Compound B can help identify the changes and accumulation in beta amyloid plaque, which is linked to Alzheimer's disease. The method could help determine possible disease development years before signs of dementia show. Another study conducted by U.S. researchers showed that the use of PET/CT with a fluorine-based radioisotope called anti-F18 FACBC detected recurrent prostate cancer with 74% accuracy and metastatic cancers with 96% accuracy.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA